会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • Stereoscopic Image Generation Apparatus, Stereoscopic Image Generation Method, and Program
    • 立体图像生成装置,立体图像生成方法和程序
    • US20100201783A1
    • 2010-08-12
    • US12671367
    • 2009-06-02
    • Kazuhiko UedaMasami OgataYasunari HatasawaShinichiro GomiYusuke Nakamura
    • Kazuhiko UedaMasami OgataYasunari HatasawaShinichiro GomiYusuke Nakamura
    • G06K9/00
    • G02B27/2228G06T15/20H04N13/302H04N13/363H04N13/373
    • Influences of physiological stereoscopic elements are removed by image processing using projection transformation. A horopter-plane image projection unit 311 is designed to project a non-stereo image supplied via a signal line 129 onto a cylindrical plane (horopter plane) including a horopter circle. The size of the horopter circle is specified using, for example, the radius as horopter circle information. Additionally, the relationship with two eyes is specified by the interocular distance. A display surface right-eye projection unit 316 is designed to project an image projected on the horopter plane onto a display surface for the right eye. A display surface left-eye projection unit 317 is designed to project the image projected on the horopter plane onto a display surface for the left eye. Therefore, retinal images that are identical to each other are supplied to the two eyes to remove influences of physiological stereoscopic elements, and stereoscopic depth is given.
    • 通过使用投影变换的图像处理去除生理立体元素的影响。 双平面图像投影单元311被设计成将经由信号线129提供的非立体声图像投影到包括双眼立方圆的圆柱面(双眼飞机平面)上。 使用例如半径作为双眼圆圈信息来指定双眼轮的大小。 另外,两只眼睛之间的关系由眼间距离指定。 显示表面右眼投影单元316被设计成将投影在双眼器飞机上的图像投影到用于右眼的显示表面上。 显示表面左眼投影单元317被设计成将投影在双眼器平面上的图像投影到用于左眼的显示表面上。 因此,将彼此相同的视网膜图像提供给两只眼睛以去除生理立体元件的影响,并给出立体深度。
    • 13. 发明授权
    • Stereoscopic image generation apparatus, stereoscopic image generation method, and program
    • 立体图像生成装置,立体图像生成方法和程序
    • US09507165B2
    • 2016-11-29
    • US12671367
    • 2009-06-02
    • Kazuhiko UedaMasami OgataYasunari HatasawaShinichiro GomiYusuke Nakamura
    • Kazuhiko UedaMasami OgataYasunari HatasawaShinichiro GomiYusuke Nakamura
    • H04N13/02G02B27/22G06T15/20H04N13/04
    • G02B27/2228G06T15/20H04N13/302H04N13/363H04N13/373
    • Influences of physiological stereoscopic elements are removed by image processing using projection transformation. A horopter-plane image projection unit 311 is designed to project a non-stereo image supplied via a signal line 129 onto a cylindrical plane (horopter plane) including a horopter circle. The size of the horopter circle is specified using, for example, the radius as horopter circle information. Additionally, the relationship with two eyes is specified by the interocular distance. A display surface right-eye projection unit 316 is designed to project an image projected on the horopter plane onto a display surface for the right eye. A display surface left-eye projection unit 317 is designed to project the image projected on the horopter plane onto a display surface for the left eye. Therefore, retinal images that are identical to each other are supplied to the two eyes to remove influences of physiological stereoscopic elements, and stereoscopic depth is given.
    • 通过使用投影变换的图像处理去除生理立体元素的影响。 双平面图像投影单元311被设计成将经由信号线129提供的非立体声图像投影到包括双眼立方圆的圆柱面(双眼飞机平面)上。 使用例如半径作为双眼圆圈信息来指定双眼轮的大小。 另外,两只眼睛之间的关系由眼间距离指定。 显示表面右眼投影单元316被设计成将投影在双眼器飞机上的图像投影到用于右眼的显示表面上。 显示表面左眼投影单元317被设计成将投影在双眼器平面上的图像投影到用于左眼的显示表面上。 因此,将彼此相同的视网膜图像提供给两只眼睛以去除生理立体元件的影响,并给出立体深度。
    • 16. 发明授权
    • Image processing apparatus, method, and program for adding shadow information to images
    • 用于将影像信息添加到图像的图像处理装置,方法和程序
    • US08265417B2
    • 2012-09-11
    • US12252559
    • 2008-10-16
    • Yusuke NakamuraShinichiro GomiMasami Ogata
    • Yusuke NakamuraShinichiro GomiMasami Ogata
    • G06K9/40H04N9/74
    • G06T5/10G06T5/007G06T7/13G06T7/40
    • An image processing apparatus processes an input image while also considering the luminous intensity information thereof, and thereby generates an output image wherein the apparent object surface roughness has been enhanced with respect to the input image. The image processing apparatus includes a luminous intensity information separator that separates the input image information into global luminous intensity information and local luminous intensity information, a shadow component generator that generates a shadow component of the image on the basis of the local luminous intensity information, and an image compositor that generates an output image by adding shadow image information to the input image information, with the shadow image information being generated from the shadow component and from a value based on the input image information.
    • 图像处理装置在考虑其输出图像的同时考虑其输入图像,并且产生相对于输入图像增强了表观物体表面粗糙度的输出图像。 该图像处理装置包括将输入图像信息分离为全局发光强度信息和局部发光强度信息的发光强度信息分离器,基于局部发光强度信息生成图像的阴影分量的阴影分量发生器,以及 图像合成器,其通过将阴影图像信息添加到输入图像信息,并且从阴影分量生成阴影图像信息和基于输入图像信息的值来生成输出图像。
    • 19. 发明授权
    • ECT2 peptides and vaccines including the same
    • ECT2肽和疫苗包括它们
    • US08951975B2
    • 2015-02-10
    • US13638272
    • 2011-03-30
    • Yusuke NakamuraTakuya TsunodaRyuji OhsawaSachiko YoshimuraTomohisa Watanabe
    • Yusuke NakamuraTakuya TsunodaRyuji OhsawaSachiko YoshimuraTomohisa Watanabe
    • A61K38/08A61K38/10A61K38/00A61K38/04C07K7/06A61K39/00
    • C07K7/06A61K39/0011A61K2039/572
    • Isolated peptides derived from SEQ ID NO: 42 and fragments thereof that bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL) and thus are suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines, are described herein. The inventive peptides encompass both the afore-mentioned amino acid sequences and modified versions thereof, in which one, two, or several amino acids are substituted, deleted, inserted or added, provided such modified versions retain the requisite HLA binding and/or CTL inducibility of the original sequences. Further provided are nucleic acids encoding any of the aforementioned peptides as well as pharmaceutical agents, substances and/or compositions that include or incorporate any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of this invention find particular utility in the treatment of cancers and tumors, including, for example, bladder cancer, breast cancer, cervical cancer, cholangiocellular carcinoma, CML, colorectal cancer, esophageal cancer, NSCLC, lymphoma, pancreatic cancer, prostate cancer, renal carcinoma and SCLC.
    • 衍生自SEQ ID NO:42的分离的肽及其与HLA抗原结合并诱导细胞毒性T淋巴细胞(CTL)的片段,因此适用于癌症免疫治疗,特别是癌症疫苗的上下文中。 本发明的肽包括上述氨基酸序列及其修饰形式,其中一个,两个或几个氨基酸被取代,缺失,插入或添加,只要这些修饰版本保留所需的HLA结合和/或CTL诱导性 的原始序列。 还提供了编码任何前述肽的核酸以及包括或掺入任何前述肽或核酸的药物,物质和/或组合物。 本发明的肽,核酸,药物,物质和组合物在治疗癌症和肿瘤方面特别有用,包​​括例如膀胱癌,乳腺癌,子宫颈癌,胆管细胞癌,CML,结肠直肠癌,食管癌 ,NSCLC,淋巴瘤,胰腺癌,前列腺癌,肾癌和SCLC。